- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-inflammatory therapeutics are drugs used to treat inflammation that occurs after tissues are injured. There are two types of anti-inflammatory therapeutics: one is steroidal anti-inflammatory therapeutics, and the other is non-steroidal anti-inflammatory therapeutics, which are antipyretic and analgesic anti-inflammatory therapeutics referred to in medical practice, such as aspirin.
There are many inflammations that have not yet found a suitable diagnosis and treatment method. The intake of anti-inflammatory therapeutics can greatly reduce the pain caused by inflammation, and the cost is less than that of surgery. However, taking anti-inflammatory therapeutics will bring certain side effects, which hinders the development of the market to a certain extent.
The increasing incidence of chronic inflammation and autoimmune diseases has increased the demand for anti-inflammatory therapeutics. In addition, it is expected that the increasing awareness of anti-inflammatory therapeutics and the active measures of governments in the Asia-Pacific region will drive market growth. The research and development of new anti-inflammatory therapeutics by major developers in the market provides opportunities for the development of the anti-inflammatory therapeutics market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anti-inflammatory Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anti-inflammatory Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Anti-inflammatory Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis AG
GlaxoSmithKline plc
AstraZeneca PLC
Amgen Inc
Eli Lily and Company
Johnson & Johnson
By Type:
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
Other
By End-User:
Arthritis
Psoriasis
Respiratory Disease
Multiple Sclerosis
Inflammatory Bowel Disease
Other Inflammatory Disease
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-inflammatory Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2016 to 2027
-
1.3.2 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2016 to 2027
-
1.3.3 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
1.3.4 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
1.3.5 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2016 to 2027
-
1.4.2 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
1.4.3 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2016 to 2027
-
1.4.4 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2016 to 2027
-
1.4.5 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2016 to 2027
-
1.4.6 USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-inflammatory Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-inflammatory Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
-
3.4.2 Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
-
3.4.3 Market Size and Growth Rate of Corticosteroids
-
3.4.4 Market Size and Growth Rate of Biologics
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Anti-inflammatory Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-inflammatory Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Arthritis
-
4.4.2 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Psoriasis
-
4.4.3 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Respiratory Disease
-
4.4.4 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Multiple Sclerosis
-
4.4.5 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Inflammatory Bowel Disease
-
4.4.6 Market Size and Growth Rate of Anti-inflammatory Therapeutics in Other Inflammatory Disease
5 Market Analysis by Regions
-
5.1 USA Anti-inflammatory Therapeutics Production Analysis by Regions
-
5.2 USA Anti-inflammatory Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Anti-inflammatory Therapeutics Landscape Analysis
-
6.1 West USA Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
7 South USA Anti-inflammatory Therapeutics Landscape Analysis
-
7.1 South USA Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Anti-inflammatory Therapeutics Landscape Analysis
-
8.1 Middle West USA Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Anti-inflammatory Therapeutics Landscape Analysis
-
9.1 Northeast USA Anti-inflammatory Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Anti-inflammatory Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novartis AG
-
10.1.1 Novartis AG Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 GlaxoSmithKline plc
-
10.2.1 GlaxoSmithKline plc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 AstraZeneca PLC
-
10.3.1 AstraZeneca PLC Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Amgen Inc
-
10.4.1 Amgen Inc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Eli Lily and Company
-
10.5.1 Eli Lily and Company Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Johnson & Johnson
-
10.6.1 Johnson & Johnson Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease from 2016 to 2027
-
Figure USA Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-inflammatory Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-inflammatory Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-inflammatory Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-inflammatory Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
-
Figure Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
-
Figure Market Size and Growth Rate of Corticosteroids
-
Figure Market Size and Growth Rate of Biologics
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-inflammatory Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-inflammatory Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Arthritis
-
Figure Market Size and Growth Rate of Psoriasis
-
Figure Market Size and Growth Rate of Respiratory Disease
-
Figure Market Size and Growth Rate of Multiple Sclerosis
-
Figure Market Size and Growth Rate of Inflammatory Bowel Disease
-
Figure Market Size and Growth Rate of Other Inflammatory Disease
-
Table USA Anti-inflammatory Therapeutics Production by Regions
-
Table USA Anti-inflammatory Therapeutics Production Share by Regions
-
Figure USA Anti-inflammatory Therapeutics Production Share by Regions in 2016
-
Figure USA Anti-inflammatory Therapeutics Production Share by Regions in 2021
-
Figure USA Anti-inflammatory Therapeutics Production Share by Regions in 2027
-
Table USA Anti-inflammatory Therapeutics Consumption by Regions
-
Table USA Anti-inflammatory Therapeutics Consumption Share by Regions
-
Figure USA Anti-inflammatory Therapeutics Consumption Share by Regions in 2016
-
Figure USA Anti-inflammatory Therapeutics Consumption Share by Regions in 2021
-
Figure USA Anti-inflammatory Therapeutics Consumption Share by Regions in 2027
-
Table West USA Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table West USA Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table South USA Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Anti-inflammatory Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Anti-inflammatory Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Anti-inflammatory Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Anti-inflammatory Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Anti-inflammatory Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of AstraZeneca PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC
-
Figure Sales and Growth Rate Analysis of AstraZeneca PLC
-
Figure Revenue and Market Share Analysis of AstraZeneca PLC
-
Table Product and Service Introduction of AstraZeneca PLC
-
Table Company Profile and Development Status of Amgen Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
-
Figure Sales and Growth Rate Analysis of Amgen Inc
-
Figure Revenue and Market Share Analysis of Amgen Inc
-
Table Product and Service Introduction of Amgen Inc
-
Table Company Profile and Development Status of Eli Lily and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily and Company
-
Figure Sales and Growth Rate Analysis of Eli Lily and Company
-
Figure Revenue and Market Share Analysis of Eli Lily and Company
-
Table Product and Service Introduction of Eli Lily and Company
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-